Pfizer, BioNtech in final stages of talks with WHO to join Covax alliance

The ultra-cold chain requirement of Pfizer's vaccine, unlike most other vaccines, makes it a challenge for most countries including India to store and transport

Pfizer and BioNtech are in the final stages of talks with the World Health Organisation (WHO) to join the Covax alliance for coronavirus vaccines, Soumya Swaminathan, WHO chief scientist, told Business Standard.
 
“Discussions are going on with Pfizer and it should be finalised in two days. We cannot tell the number of doses or pricing of the vaccine at this stage,” Swaminathan said.
 
The Covax alliance, of which India is a member, is a specially created financial instrument to help countries get equitable access to Covid-19 vaccines. The messenger RNA vaccine developed by Pfizer and BioNtech has already